Sprint Bioscience AB (publ) (FRA:5JA1)

Sprint Bioscience AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16	10	11	2	19	16
Market Cap Growth	74.36%	-11.54%	450.99%	-89.35%	14.56%	19.86%
Enterprise Value	15	7	6	-0	10	13
Last Close Price	0.13	0.13	0.12	0.03	0.44	0.70
PS Ratio	3.60	1.67	2.34	265.47	5.45	8.49
PB Ratio	29.67	11.91	4.36	0.78	2.71	17.82
P/TBV Ratio	29.67	11.91	4.36	0.78	2.71	17.82
P/FCF Ratio	-	-	5.93	-	-	-
P/OCF Ratio	-	-	5.30	-	-	-
EV/Sales Ratio	3.21	1.19	1.28	-	3.01	6.64
EV/FCF Ratio	-4.32	-	3.24	-	-	-
Debt / Equity Ratio	-	-	-	-	-	1.09
Asset Turnover	1.48	1.27	1.04	0.00	0.62	0.73
Quick Ratio	1.13	1.14	1.67	3.78	8.74	1.30
Current Ratio	1.13	1.14	1.67	3.78	8.74	1.33
Return on Equity (ROE)	-262.44%	-98.67%	-1.57%	-122.00%	-63.02%	-424.50%
Return on Assets (ROA)	-44.91%	-22.46%	-1.66%	-65.01%	-28.29%	-89.46%
Return on Capital Employed (ROCE)	-399.70%	-202.40%	-4.80%	-215.00%	-36.10%	-412.00%
Earnings Yield	-14.25%	-16.55%	-0.36%	-273.08%	-13.13%	-26.26%
FCF Yield	-21.67%	-22.32%	16.85%	-268.02%	-22.41%	-19.78%
Buyback Yield / Dilution	-19.80%	-0.01%	-65.98%	-45.85%	-71.85%	-49.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.